Chemoselective Suzuki–Miyaura Cross-Coupling Reactions of 6-Bromo-3-(trifluoromethylsulfonyloxy)flavone

Omer A. Akrawi; Tamás Patonay; Krisztina Kónya; Peter Langer

doi:10.1055/s-0032-1318479

Synlett, Inhaltsverzeichnis

Synlett 2013; 24(7): 860-864
DOI: 10.1055/s-0032-1318479

letter

Chemoselective Suzuki–Miyaura Cross-Coupling Reactions of 6-Bromo-3-(trifluoromethylsulfonyloxy)flavone

Omer A. Akrawi

^aInstitut für Chemie, Universität Rostock, Albert Einstein Str. 3a, 18059 Rostock, Germany Fax: +49(381)4986412 eMail: peter.langer@uni-rostock.de

,

Tamás Patonay

^bDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary

,

Krisztina Kónya

^bDepartment of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary

,

Peter Langer*

^aInstitut für Chemie, Universität Rostock, Albert Einstein Str. 3a, 18059 Rostock, Germany Fax: +49(381)4986412 eMail: peter.langer@uni-rostock.de

^cLeibniz-Institut für Katalyse an der Universität Rostock e.V., Albert Einstein Str. 29a, 18059 Rostock, Germany

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

Arylated flavones were prepared by Suzuki–Miyaura reactions of 6-bromo-3-(trifluoro-sulfonyloxy)flavone. The reactions proceeded with very good chemoselectivity in favor of position 3.

Key words

catalysis - flavones - heterocycles - palladium - cross-coupling reactions

Volltext

Referenzen

References and Notes

1a The Handbook of Natural Flavonoids . Harborne JB, Baxter H. 1999, Vol. 2; 8: 79
1b Aherne SA, O’Brien NM. Nutrition 2002; 18: 75
1c Middleton EJr, Kandaswami C, Theoharides TC. Pharmacol. Rev. 2000; 52: 673
1d Middleton E, Kandaswami C In The Flavanoids: Advance in Research since 1986 . Harborne JB. Chapman and Hall; London: 1994: 619
1e Wong E, Harborne JB, Mabry TJ, Mabry H. In The Flavanoids . Harborne JB, Mabry TJ, Mabry H. Chapman and Hall; London: 1975: 184

2 Malikov VM, Yuldashev MP. Chem. Nat. Compd. 2002; 38: 358
3 Huck CW, Huber CG, Ongania KH, Bonn GK. J. Chromatogr. A 2000; 453
4 Nagao T, Abe F, Kinjo J, Okabe H. Biol. Pharm. Bull. 2002; 7: 875
5 Carlo GDi, Mascolo N, Izzo AA, Capasso F. Life Sci. 1999; 65: 337
6 Perez-Vizcaino F, Ibarra M, Cogolludo AL, Duarte J, Zaragoza-Arnaez F, Moreno L, Lopez-Lopez G, Tamargo J. J. Pharmacol. Exp. Ther. 2002; 301: 66

7a Sanchez I, Gomez-Garibay F, Taboada J, Ruiz BH. Phytother. Res. 2000; 14: 89
7b Bae EA, Han MJ, Lee M, Kim DH. Biol. Pharm. Bull. 2000; 23: 1122

8a Grassmann J, Hippeli S, Elstner EF. Plant. Physiol. Biochem. 2002; 40: 471
8b Miura S, Watanabe J, Sano M, Tomita T, Osawa T, Hara Y, Tomita I. Biol. Pharm. Bull. 1995; 18: 1

9a Xu HX, Lee SF. Phytother. Res. 2001; 15: 39
9b Hamiltonmiller JM. T. Antimicrob. Agents Chemother. 1995; 39: 2375

10 Jain A, Martin MC, Parveen N, Khan NU, Parish JH, Hadi SM. Phytother Res. 1999; 13: 609
11 Landolfi R, Mower RL, Steiner M. Biochem. Pharmacol. 1984; 32: 1525
12 Yamada J, Tomita Y. Biosci. Biotech. Biochem. 1994; 58: 2197
13 Matsuo N, Yamada K, Yamashita K, Shoji K, Mori M, Sugano M. In Vitro Cell Dev. Biol. 1996; 32: 340

14a Han C. Cancer Lett. 1997; 114: 153
14b Birt DF, Hendrich S, Wang W. Pharmacol. Therap. 2001; 90: 157
14c Cushman M, Nagarathnam D. J. Nat. Prod. 1991; 54: 1656
14d Cabrera M, Simoens M, Falchi G, Lavaggi ML, Piro OE, Castellano EE, Vidal A, Azqueta A, Monge A, Lopez-Cerain A, Sagrera G, Seoane G, Cerecetto H, Gonzalez M. Bioorg. Med. Chem. 2007; 15: 3356
14e Kim KS, Kimball SD, Misra RN, Rawlins DB, Hunt JT, Xiao HY, Lu S, Qian L, Han WC, Shan W, Mitt T, Cai ZW, Poss MA, Zhu H, Sack JS, Tokarski JS, Chang CY, Pavletich N, Kamath A, Humphreys WG, Marathe P, Bursuker I, Kellar KA, Roongta U, Batorsky R, Mulheron JG, Bol D, Fairchilds CR, Lee FY, Webster KR. J. Med. Chem. 2002; 45: 3905

15 Kim HK, Son KH, Chang HW, Kang SS, Kim HP. Planta Med. 1999; 65: 465
16 Soike H, Leng-Peschlow E. Planta Med. 1987; 53: 37
17 Havsteen B. Biochem. Pharmacol. 1983; 32: 141
18 Beil W, Birkholz C, Sewing KF. Arzneim. Forsch. 1995; 45: 697
19 Goitsegen A. Proceedings of the 2nd International Meeting on Medicinal and Aromatic Plants. 1981: 117
20 Eaton-Evans J. Br. J. Biomed. Sci. 1994; 51: 358
21 Vijayaraghavan R, Sugendran K, Pant SC, Husain K, Malhotra RC. Toxicology 1991; 69: 34
22 Dicarlo G, Autore G, Izzo AA, Maiolino P, Mascolo N, Viola P, Diurno MV, Capasso F. J. Pharm. Pharmacol. 1993; 45: 1054
23 Ammar NM, El-Diwany AI. J. Islamic Acad. Sci. 1988; 1: 72
24 Polkowski K, Mazurek AP. Acta Pol. Pharm. Drug Res. 2000; 57: 135

25a Baker W. J. Chem. Soc. 1933; 1381
25b Mahal HS, Venkataraman K. J. Chem. Soc. 1934; 1767

26a Zhiyun D, Kun Z, Huifen N, Huaqiang Z, Jian W. Org. Biomol. Chem. 2011; 9: 6930
26b Hemanth KK, Paramasivan PT. Tetrahedron 2007; 63: 9531
26c Patonay T, Cavaleiro JA. S, Lévai A, Silva AM. S. Heterocycl. Commun. 1997; 3: 223

27 Yoshida M, Fujino Y, Do T. Org. Lett. 2011; 13: 4526
28 Das J, Ghosh S. Tetrahedron Lett. 2011; 52: 7189

29a Algar J, Flynn JP. Proc. Roy. Irish Acad. 1934; 42B: 1
29b Oyamada T. J. Chem. Soc. Jpn. 1934; 55: 1256
29c Smith MA, Neumann RM, Webb RA. J. Heterocycl. Chem. 1968; 5: 425
29d Montana MP, Pappano N, Giordano SO, Molina P, Debattista NB, Garcia NA. Pharmazie 2007; 62: 72

30 Yang Q, Alper H. J. Org. Chem. 2010; 75: 948
31 Rao ML. N, Venkatesh V, Jadhav DN. Synlett 2009; 2597
32 Kim D, Ham K, Hong S. Org. Biomol. Chem. 2012; 10: 7305
33 Eleya N, Malik I, Reimann S, Wittler K, Hein M, Patonay T, Villinger A, Ludwig R, Langer P. Eur. J. Org. Chem. 2012; 1639
34 6-Bromo-3-hydroxyflavone (1) was prepared by the reaction of the corresponding 2′-hydroxychalcone with ethanolic alkaline hydrogenperoxide solution,²⁹ the product was obtained after recrystallization (EtOH) in 56% yield; mp 189–191 °C, lit.^35a; mp 180–181 °C, lit.^35a; mp 183–184 °C.

35a Chang CT, Chen FC, Chen TS, Hsu KK, Hung M. J. Chem. Soc. 1961; 3414
35b Hasan A, Rasheed L, Malik A. Asian J. Chem. 2007; 19: 937

36 Synthesis of 6-Bromo-4-oxo-2-phenyl-4H-chromen-3-yl Trifluoromethanesulfonate (2) Tf₂O (0.53 mL, 3.20 mmol) was added at 0 °C to a solution of 1 (0.5 g, 1.58 mmol) and pyridine (0.64 mL, 7.88 mmol) in CH₂Cl₂ (15 mL). The reaction mixture was stirred at r.t. under argon atmosphere for 18 h. To the reaction mixture was added toluene (10 mL), and the solution was concentrated in vacuo. The residue was purified by chromatography (EtOAc–heptanes) without aqueous workup to yield 2 as a white solid (0.674 g, 95%); mp 160–162 °C. ¹H NMR (300 MHz, CDCl₃): δ = 7.42 (d, 1 H, J = 8.9 Hz, ArH), 7.48–7.60 (m, 3 H, ArH), 7.77–7.81 (m, 3 H, ArH), 8.35 (d, 1 H, J = 2.5 Hz, ArH). ¹⁹F NMR (282.4 MHz, CDCl₃): δ = –73.7. ¹³C NMR (62.9 MHz, CDCl₃): δ = 118.20 (q, J _C,F = 320.9, CF₃), 119.7 (C), 120.2 (CH), 124.8, 128.1 (C), 128.2 (2 CH), 129.0, 132.7 (CH), 133.8 (C), 137.8 (CH), 154.2, 159.2 (C), 170.0 (CO). IR (KBr): ν = 3083, 3070, 2928 (w), 1651, 1620 (s), 1604, 1538, 1496, 1461, 1451 (m), 1425 (s), 1367 (m), 1335, 1321, 1292, 1269, 1250, 1232 (w), 1212, 1201, 1170, 1139, 1120 (s), 1078, 1060, 1033 (w), 990 (m), 975, 932, 912, 894 (w), 856, 827, 804 (s), 784 (w), 767, 764 (s), 711 (m), 693, 678, 661 (s), 646 (m), 619 (s), 571, 559, 545, 529 (m) cm^–1. GC–MS (EI, 70 eV): m/z (%) = 450 (13) [M, ⁸¹Br]⁺, 448 (13) [M, ⁷⁹Br]⁺, 319 (12), 318 (59), 317 (35), 316 (59), 315 (53), 290 (19), 289 (100), 287 (95), 261 (17), 259 (12). HRMS (EI, 70 eV): m/z calcd for C₁₆H₈BrF₃O₅S [M, ⁷⁹Br]⁺: 447.92224; found: 447.92265; m/z calcd. for C₁₆H₈BrF₃O₅S [M, ⁸¹Br]⁺: 449.92020; found: 449.92043.
37 General Procedure for the Synthesis of 4a–g A 1,4-dioxane solution of 2 (0.11 mmol), arylboronic acid (2.3 equiv), K₃PO₄ (3.0 equiv), and Pd(PPh₃)₄ (6 mol%) was heated at 90 °C for 12 h under argon atmosphere. After cooling to 20 °C, H₂O was added, and the reaction mixture was extracted with CH₂Cl₂ (3 × 25 mL). Organic layers were dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was purified by column chromatography (EtOAc–heptanes)
38 3,6-Bis(4-methoxyphenyl)-2-phenyl-4H-chromen-4-one (4a) Starting with 2 (50 mg, 0.11 mmol), (4-methoxyphenyl)boronic acid (39 mg, 0.26 mmol), K₃PO₄ (70 mg, 0.33 mmol), and Pd(PPh₃)₄ (8 mg, 6 mol%), 4a was prepared as a white solid (48 mg, 90%); mp 181–183 °C. Reaction temperature: 90 °C for 12 h. ¹H NMR (250 MHz, CDCl₃): δ = 3.73 (s, 3 H, OCH₃), 3.79 (s, 3 H, OCH₃), 6.77 (d, 2 H, J = 8.8 Hz, ArH), 6.94 (d, 2 H, J = 8.8 Hz, ArH), 7.08 (d, 2 H, J = 8.8 Hz, ArH), 7.18–7.28 (m, 3 H, ArH), 7.34–7.38 (m, 2 H, ArH), 7.49 (d, 1 H, J = 8.7 Hz, ArH), 7.55 (d, 2 H, J = 8.8 Hz, ArH), 7.82 (dd, 1 H, J = 8.8, 2.4 Hz, ArH), 8.37 (d, 1 H, J = 2.3 Hz, ArH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 55.2, 55.4, (OCH₃), 113.9, 114.4, 118.4, (CH), 122.4 (C), 123.0 (CH), 123.6 125.0 (C), 128.1, 128.3, 129.6, 129.9 (CH), 132.1 (C), 132.2, 132.4 (CH), 133.5, 137.8, 155.1, 159.0, 159.5, 161.2 (C), 177.7 (CO). IR (KBr): ν = 3060, 3035, 2954, 2929, 2834 (w), 1633, 1605 (s), 1580, 1563 (m), 1557 (s), 1538 (w), 1511 (m), 1494 (w), 1479, 1446, 1439, 1410 (s), 1291, 1282, 1268 (m), 1244, 1229, 1179 (s), 1149, 1122, 1106, 1079, 1055 (w), 1031, 1018 (m), 1005, 973 (w), 928 (m), 916, 905, 848 (w), 835 (m), 813 (s), 797, 770 (m), 732, 709 (w), 689 (m), 673, 661, 652, 639, 624, 584, 579, 563 (w), 585, 539 (m) cm^–1. GC–MS (EI, 70 eV): m/z (%) = 434 (76) [M]⁺, 433 (100) [M – H]⁺, 418 (4), 390 (6), 311 (24), 226 (4). HRMS (EI, 70 eV): m/z calcd for C₂₉H₂₂O₄ [M]⁺: 434.15126; found: 434.14966; m/z calcd for C₂₉H₂₁O₄ [M – H]⁺: 433.14344; found: 433.14334.
39 General Procedure for the One-Pot Synthesis of 5a–g A toluene–MeOH (9:1) solution of 2 (0.11 mmol), arylboronic acid (1.1 equiv), K₃PO₄ (1.5 equiv), and Pd(PPh₃)₄ (3 mol%) was heated at 65 °C for 24 h under argon atmosphere. After cooling to 20 °C, H₂O was added, and the reaction mixture was extracted with CH₂Cl₂ (3 × 25 mL). The organic layers were dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was purified by column chromatography (EtOAc–heptanes)
40 6-Bromo-3-(4-methoxyphenyl)-2-phenyl-4H-chromen-4-one (5a)
Starting with 2 (50 mg, 0.11 mmol), 5a was prepared as a white solid (37 mg, 82%), mp 237–238 °C. Reaction temperature: 65 °C for 24 h. ¹H NMR (300 MHz, CDCl₃): δ = 3.73 (s, 3 H, OCH₃), 6.77 (d, 2 H, J = 8.9 Hz, ArH), 7.06 (d, 2 H, J = 8.9 Hz, ArH), 7.19–7.37 (m, 6 H, ArH), 7.70 (dd, 1 H, J = 8.9, 2.5 Hz, ArH), 8.33 (d, 1 H, J = 2.5 Hz, ArH). ¹³C NMR (62.9 MHz, CDCl₃): δ = 55.2 (OCH₃), 113.9 (CH), 118.3 (C), 119.9 (CH), 122.6, 124.4, 124.8 (C), 128.2, 128.9, 129.5, 130.1, 132.3 (CH), 133.1 (C), 136.5 (CH), 154.8, 159.1, 161.4 (C), 176.3 (CO). IR (KBr): ν = 3081, 3059, 3015, 2928, 2850, 2832 (w), 1635, 1604 (s), 1574, 1563 (w), 1556 (s), 1510 (w), 1466, 1455, 1444 (m), 1426, 1361 (s), 1288, 1270 (m), 1232, 1219, 1177 (s), 1146, 1121, 1107, 1061, 1048 (w), 1027, 1000 (s), 976, 960 (w), 928 (m), 906, 896, 841 (w), 824, 815 (s), 794 (w), 777 (s), 728 (w), 701, 696, 676, 666, 653, 648 (m), 640, 619, 610, 551 (w), 540, 530 (m) cm^–1. GC–MS (EI, 70 eV): m/z (%) = 408 (67) [M, ⁸¹Br]⁺, 407 (100) [M – H, ⁸¹Br]⁺, 406 (69) [M, ⁷⁹Br]⁺, 405 (84) [M – H, ⁷⁹Br]⁺, 364 (5), 362 (5), 327 (7), 283 (6), 255 (6), 226 (5), 208 (22). HRMS (ESI-TOF/MS): m/z calcd. for C₂₂H₁₆BrO₃ [M + H, ⁷⁹Br]⁺: 407.02773; found: 407.0270; m/z calcd for C₂₂H₁₆BrO₃ [M + H, ⁸¹Br]⁺: 409.02597; found: 409.02509.
41 General Procedure for the One-Pot Synthesis of 6a–d A toluene–MeOH (9:1) solution of 2 (0.17 mmol), Ar¹B(OH)₂ (1.0 equiv), K₃PO₄ (1.5 equiv), and Pd(PPh₃)₄ (3 mol%) was heated at 65 °C for 36 h under argon atmosphere. After cooling to 20 °C, Ar²B(OH)₂ (1.3 equiv), Pd(PPh₃)₄ (6 mol%), and MeOH (0.2 mL) were added, and the reaction mixture was heated at 105 °C for further 12 h. The reaction mixture was cooled again to 20 °C, H₂O was added, and the reaction mixture was extracted with CH₂Cl₂ (3 × 25 mL).The combined organic layers were dried over Na₂SO₄, filtered, and the filtrate was concentrated in vacuo. The residue was purified by column chromatography (EtOAc–heptanes)
42 3-(4-Ethoxyphenyl)-2-phenyl-6-(m-tolyl)-4H-chromen-4-one (6c)
Starting with 2 (75 mg, 0.17 mmol), (4-ethoxyphenyl)boronic acid as Ar¹B(OH)₂ (29 mg, 0.17 mmol), K₃PO₄ (53 mg, 0.26 mmol), Pd(PPh₃)₄ (6 mg, 3 mol%), and (3-methylphenyl)boronic acid as Ar²B(OH)₂ (30 mg, 0.22 mmol), 6c was prepared as a light yellow highly viscous oil (66 mg, 91%). Reaction temperature: 65 °C for 36 h, then 105 °C for 12 h. ¹H NMR (300 MHz, CDCl₃): δ = 1.33 (t, 3 H, J = 7.0 Hz, CH₃), 2.36 (s, 3 H, CH₃), 3.95 (q, 2 H, J = 7.0 Hz, OCH₂), 6.75 (d, 2 H, J = 8.8 Hz, ArH), 7.07 (d, 2 H, J = 8.8 Hz, ArH), 7.11–7.31 (m, 5 H, ArH), 7.34–7.43 (m, 4 H, ArH), 7.50 (d, 1 H, J = 8.7 Hz, ArH), 7.84 (dd, 1 H, J = 8.7, 2.3 Hz, ArH), 8.41 (d, 1 H, J = 2.3 Hz, ArH). ¹³C NMR (75.5 MHz, CDCl₃): δ = 14.9, 21.6 (CH₃), 63.4 (OCH₂), 114.4, 118.4 (CH), 122.5, 123.6 (C), 124.1, 124.3 (CH), 124.8 (C), 128.0, 128.1, 128.5, 128.9, 129.6, 129.9, 132.4, 132.6 (CH), 133.5, 138.3, 138.7, 139.5, 155.4, 158.5, 161.2 (C), 177.7 (CO). IR (KBr): ν = 3055, 3034, 2975, 2922, 2871 (w), 1636, 1606 (s), 1558 (m), 1510 (s), 1494 (w), 1474 (s), 1444 (m), 1405, 1393 (w), 1361 (s), 1285, 1270 (w), 1224, 1174 (s), 1143, 1114, 1094, 1076 (w), 1041, 1029 (m), 1012, 1000, 933, 919, 845 (w), 825, 782, 769, 729, 718, 692 (s), 665 (w), 643, 631 (m), 597, 564, 531 (w) cm^–1. GC–MS (EI, 70 eV): m/z (%) = 432 (79) [M]⁺, 431 (100) [M – H]⁺, 403 (18), 375 (5), 222 (10). HRMS (EI, 70 eV): m/z calcd for C₃₀H₂₄O₃ [M]⁺: 432.17200; found: 432.17124.
43 Joo YH, Kim JK. Kang S.-H, Noh M.-S, Ha J.-Y, Choi JK, Lim KM, Lee CH, Chung S. Bioorg. Med. Chem. 2003; 13: 413

For reviews of site-selective palladium(0)-catalyzed cross-coupling reactions, see:

44a Schröter S, Stock C, Bach T. Tetrahedron 2005; 61: 2245
44b Schnürch M, Flasik R, Khan AF, Spina M, Mihovilovic MD, Stanetty P. Eur. J. Org. Chem. 2006; 3283
44c Wang R, Manabe K. Synthesis 2009; 1405

45a Kamikawa T, Hayashi T. Tetrahedron Lett. 1997; 38: 7087
45b Littke AF, Dai CY, Fu GC. J. Am. Chem. Soc. 2000; 122: 4020
45c Roy AH, Hartwig JF. Organometallics 2004; 23: 194
45d Espinet P, Echavarren AM. Angew. Chem. Int. Ed. 2004; 43: 4704
45e Espino G, Kurbangalieva A, Brown JM. Chem. Commun. 2007; 1742 ; and references cited therein

46 Akrawi OA, Nagy GZ, Patonay T, Villinger A, Langer P. Tetrahedron Lett. 2012; 53: 3206